-
Food Protein Biotech Adds €4M in Seed Funds
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds.
-
Cell Biology Tools Companies Merge in $57.8M Deal
Two providers of technologies for cellular analysis are merging to form a new company focusing on cell biology research tools, in a sign of continued industry consolidation.
-
Immune Organoid Company Raises $4.3M in Seed Funds
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds.
-
Personal Allergy Start-Up Gains $16.5M in Early Funds
A new business that provides personalized allergy testing, drug making, and delivery to consumers is raising $16.5 million in its first venture funding round.
-
Trial Shows Gel Clears Common Skin Cancer Wounds
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors.
-
Bye-Bye Bluebird
In mid-November we removed our Twitter feed display in the right-hand column. Yesterday, we decided to leave Twitter altogether.
-
Brain-Computer Interface Company Raises $75M in New Funds
A developer of an implanted electronic system that captures and transmits thoughts of movement into signals for digital devices is raising $75 million in venture funds.
-
Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer.
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Mental Health VR Companies Merge, Raise $13M
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds.